Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 397843-58-2 | MDL No. : | MFCD08060623 |
Formula : | C11H16BNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VTSDPGUSDVMXDN-UHFFFAOYSA-N |
M.W : | 221.06 | Pubchem ID : | 11031409 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.45 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 66.24 |
TPSA : | 52.93 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.44 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.29 |
Log Po/w (WLOGP) : | -1.33 |
Log Po/w (MLOGP) : | -0.27 |
Log Po/w (SILICOS-IT) : | -0.35 |
Consensus Log Po/w : | -0.33 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.47 |
Solubility : | 7.44 mg/ml ; 0.0337 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.96 |
Solubility : | 24.0 mg/ml ; 0.109 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.89 |
Solubility : | 2.87 mg/ml ; 0.013 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.94 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1426245-63-7 ]
(3-Methyl-4-morpholinophenyl)boronic acid
Similarity: 0.85
[ 70799-12-1 ]
4-((Dimethylamino)methyl)phenylboronic acid
Similarity: 0.84
[ 1485417-01-3 ]
(3-((Dimethylamino)methyl)phenyl)boronic acid hydrochloride
Similarity: 0.83
[ 938465-64-6 ]
(4-((Dimethylamino)methyl)phenyl)boronic acid hydrochloride
Similarity: 0.83
[ 1146614-39-2 ]
(3-((Methylamino)methyl)phenyl)boronic acid
Similarity: 0.82
[ 1426245-63-7 ]
(3-Methyl-4-morpholinophenyl)boronic acid
Similarity: 0.85
[ 70799-12-1 ]
4-((Dimethylamino)methyl)phenylboronic acid
Similarity: 0.84
[ 1485417-01-3 ]
(3-((Dimethylamino)methyl)phenyl)boronic acid hydrochloride
Similarity: 0.83
[ 938465-64-6 ]
(4-((Dimethylamino)methyl)phenyl)boronic acid hydrochloride
Similarity: 0.83
[ 1146614-39-2 ]
(3-((Methylamino)methyl)phenyl)boronic acid
Similarity: 0.82
[ 1426245-63-7 ]
(3-Methyl-4-morpholinophenyl)boronic acid
Similarity: 0.85
[ 364794-79-6 ]
4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine
Similarity: 0.76
[ 364794-80-9 ]
4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine
Similarity: 0.75
[ 186498-02-2 ]
(4-Morpholinophenyl)boronic acid
Similarity: 0.74
[ 863377-22-4 ]
(3-Morpholinophenyl)boronic acid
Similarity: 0.73
[ 1426245-63-7 ]
(3-Methyl-4-morpholinophenyl)boronic acid
Similarity: 0.85
[ 364794-79-6 ]
4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine
Similarity: 0.76
[ 364794-80-9 ]
4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine
Similarity: 0.75
[ 186498-02-2 ]
(4-Morpholinophenyl)boronic acid
Similarity: 0.74
[ 863377-22-4 ]
(3-Morpholinophenyl)boronic acid
Similarity: 0.73